The *CACNA1C* gene encoding the Ca~v~1.2 subunit of the L-type calcium channel has emerged as a new candidate gene for neuropsychiatric disease, including bipolar disorder, major depression, schizophrenia and autism.^[@bib1],\ [@bib2],\ [@bib3]^ We report that global haploinsufficiency, forebrain-specific elimination and prefrontal cortex (PFC)-specific knockdown of *cacna1c* all increase anxiety-related behavior in mice, a prominent component of the forms of neuropsychiatric disease in which aberrations in *CACNA1C* have been implicated, without affecting compulsive behavior.

Constitutive *cacna1c* heterozygous mice (*HET*) were evaluated in three behavioral assays related to anxiety: open field test, light--dark conflict test and elevated plus maze (EPM). *HET*s displayed anxiety-like behavior in the EPM ([Figure 1a](#fig1){ref-type="fig"}), spending significantly less time exploring the open arms compared with wild-type littermate controls (WT; *F*~1,19~=6.437; *P*\<0.05). However, no differences were observed between *HET*s and WTs in the open field and light--dark conflict test, ([Figures 1a and b](#fig1){ref-type="fig"}, [Supplementary Material](#sup1){ref-type="supplementary-material"}). We also observed a similar statistically significant effect of increased anxiety-like behavior compared with WTs in EPM in adult female *HETs* ([Figure 1d](#fig1){ref-type="fig"}, [Supplementary Material](#sup1){ref-type="supplementary-material"}) and adolescent male *HET*s ([Figure 1e](#fig1){ref-type="fig"}, [Supplementary Material](#sup1){ref-type="supplementary-material"}). To more specifically investigate the function of *cacna1c* in the brain, we generated forebrain-specific conditional *cacna1c-*deficient mice (*forebrain-cacna1c cKO*) by crossing *cacna1c*-floxed mice with mice harboring alphaCaM Kinase II promoter-driven expression of Cre recombinase.^[@bib4]^ Relative to WTs, this strategy achieved ∼70% elimination of *cacna1c* mRNA in the hippocampus, PFC, basolateral amygdala, striatum and nucleus accumbens, as assessed by quantitative PCR ([Table 1, Supplementary Material](#sup1){ref-type="supplementary-material"}). *Cacna1c* mRNA levels were unaffected in the ventral tegmental area and cerebellum. With this greater reduction in *cacna1c* in forebrain than could be achieved in *HET*s, significantly increased anxiety-like behavior was observed across all three behavioral assays. In EPM, *forebrain-cacna1c cKO* mice spent significantly less time exploring the open arms compared with WTs ([Figure 1b](#fig1){ref-type="fig"}, *F*~1,16~=68.587; *P*\<0.0001 and [Figure 2c, Supplementary Material](#sup1){ref-type="supplementary-material"}). In the open field test, *forebrain-cacna1c cKO* mice spent less time exploring the center of the chamber compared with WTs ([Figures 2a and 3a, Supplementary Material](#sup1){ref-type="supplementary-material"}). In the light-dark conflict test, *forebrain-cacna1c cKO* mice spent significantly less time in the brightly lit side compared with WTs ([Figures 2b and 3b, Supplementary Material](#sup1){ref-type="supplementary-material"}).

Clinically, anxiety is often accompanied by compulsive behavior, such as in obsessive-compulsive disorder (OCD), in which patients seek alleviation from recurrent bouts of anxiety-inducing intrusive thoughts by engaging in compulsively repetitive behaviors. Experimental models for OCD, such as *SAPAP3-*^[@bib5]^ or *SLITRK5-*deficient^[@bib6]^ mice, display pathologically high compulsive grooming that is readily quantified by the spray-induced grooming test. Compared with respective WTs, we did not observe elevated grooming in either *HET*s or *forebrain-cacna1c cKO* mice ([Figures 1c and 3c, Supplementary Material](#sup1){ref-type="supplementary-material"}). Thus, the form of anxiety associated with *cacna1c* function is distinct from that associated with OCD spectrum illnesses.

Some genetic variations in *CACNA1C* have been associated with altered PFC function^[@bib7],\ [@bib8],\ [@bib9]^ in neuropsychiatric disease, so we next generated focal elimination of *cacna1c* in the PFC with adeno-associated viral (AAV) vector-expressing Cre recombinase (AAV-Cre).^[@bib10]^ AAV-Cre was stereotaxically delivered bilaterally into the PFC of floxed *cacna1c* mice, and regional elimination of Ca~v~1.2 was immunohistochemically confirmed ([Figures 1d and e](#fig1){ref-type="fig"}). Following elimination of *cacna1c* in the PFC, mice showed no differences in basal locomotor activity compared with AAV-GFP control injected mice ([Figure 4, Supplementary Material](#sup1){ref-type="supplementary-material"}). However, selective elimination of *cacna1c* in the PFC was associated with less time spent exploring open arms of the EPM, compared with control AAV-GFP injected mice ([Figure 1c](#fig1){ref-type="fig"}, *F*~1,16~=5.477; *P*\<0.05). To evaluate the specificity of PFC *cacna1c* knockdown in mediating anxiety, we used AAV-expressing *cacna1d* siRNA^[@bib10]^ to selectively eliminate *cacna1d* in the PFC, the other L-type Ca^2+^ channel isoform expressed in brain. Selective knockdown of *cacna1d* in the PFC had no effect on locomotor behavior ([Figure 5a, Supplementary Material](#sup1){ref-type="supplementary-material"}) or time spent in open arms in the EPM ([Figure 5b, Supplementary Material](#sup1){ref-type="supplementary-material"}).

In summary, we report here the first direct evidence for a role of forebrain *cacna1c* in regulating anxiety. Mice harboring forebrain-specific elimination of *cacna1c* may thus provide a useful tool for studying the pathophysiology of anxiety in forms of neuropsychiatric diseases in which *CACNA1C* is implicated.
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![Anxiety-like behavior as measured in the elevated plus maze (EPM) assay is shown for (**a**) *cacna1c* haplosufficient (*cacna1c* HET; *n*=10) and wild-type (WT; *n*=11) littermates, (**b**) forebrain-specific *cacna1c* knockout (*forebrain*-*cacna1c* cKO; *n*=8) and WT controls (*n*=10), and (**c**) prefrontal cortex (PFC)-specific *cacna1c* knockdown (PFC-*cacna1c* KD; *n*=8) and control virus (*n*=7) microinjected mice. Decreased time in the open arm of the EPM reflects anxious-like behavior. Data are presented as mean (±s.e.m.) percent time spent in the open arms. ^\*^*P*\<0.05, ^\*\*^*P*\<0.01 and ^\*\*\*^*P*\<0.001, *Bonferroni-Dunn posthoc* test. (**d**) Representative image of green fluorescent protein (GFP)-positive cells expressed by AAV-Cre-GFP stereotaxically microinjected into the PFC of *cacna1c*-floxed mice is shown. (**e**) Double immunohistochemical analysis with GFP and Ca~v~1.2 antibodies is shown. Successful knockdown of Ca~v~1.2 protein in the PFC was confirmed by the lack of co-localization of GFP and Ca~v~1.2 in the same cells. Also shown is a representative image of GFP and Ca~v~1.2 co-localization (blue arrows) in PFC neurons of control AAV-GFP microinjected mice.](mp201271f1){#fig1}
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